Business Standard

Letter to BS: Dexamethasone has a better chance to reach patients worldwide

Dexamethasone reduced the 28-day mortality rate by 17 per cent

Dexamethasone
Premium

Business Standard
Researchers in England say they have the first evidence that a drug can improve Covid-19 survival. A cheap, widely available steroid called dexamethasone reduced deaths by up to a third in severely ill patients. This is good news for India. One saved life for every eight to 25 people treated may not seem like much, but there are thousands of people hospitalised around the world right now who could benefit from this medicine, and thousands more are likely to join them if current trends continue. This drug has a better chance than most to reach patients worldwide and could lead

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 17 2020 | 11:51 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com